UK-based ReGen Therapeutics has preliminary evidence of an anti-ageing effect from its nutraceutical Colostrinin. The colostrum-based product increased the lifespan of cells isolated from mice predisposed to premature ageing and therefore, death, researchers will report today at the 21st International Conference of Alzheimer’s Disease International taking place in Istanbul.
